The merger will combine URA's exclusive technology and expertise with Diamond Institute's best fertility specialists to create one of the strongest networks of fertility clinics in northern New Jersey and New York.
URA | Diamond logo
HASBROUCK HEIGHTS, N.J., July 11, 2023 (Newswire.com)
University Reproductive Associates (URA) and Diamond Institute today announced a merger that will create one of the most technologically advanced networks of fertility clinics in northern New Jersey and New York, as well as the most personalized. Both URA and Diamond Institute have built their successes on excellence in care, from initial evaluation to guidance on financial assistance. That care will now be available at six offices in six counties. New Jersey offices: Hasbrouck Heights in Bergen County, Wayne in Passaic County, Millburn in Essex County, Denville in Morris County and Hoboken in Hudson County. New York office: Goshen in Orange County.
According to Peter McGovern, M.D., a founding physician at URA, the merger will result in a new level of fertility care and solutions as more treatment options will be available, delivered with the one-on-one, personal care for which both organizations are known among their patients. URA is already the first and only fertility clinic network in New Jersey to offer the LifeAire in-duct air purification system, leading to a 15%-20% higher chance of successful implantation and pregnancy. URA is also the only network of fertility clinics in New Jersey to offer robotic surgery using the da Vinci® Surgical System.
From Diamond Institute, the merger will bring to URA two leading fertility specialists in New Jersey, Dr. Matan Yemini and Dr. Ndidiamaka Onwubalili. Dr. Yemeni brings 30 years of experience focusing interest, practice and research on the spectrum of issues associated with reproductive endocrinology and infertility treatment. Dr. Yemeni is bilingual, also speaking Hebrew. Dr. Onwubalili, aka “Dr. O,” is board-certified in Obstetrics and Gynecology and Reproductive Endocrinology. She is a Fellow of the American Congress of Obstetricians, and her clinical and research focus includes polycystic ovarian syndrome, fertility preservation, uterine fibroids, and minimally invasive surgery.
“There’s no doubt that URA provides families-to-be with higher chances than most fertility clinics through technology. Combined with the warm, personal care that’s already our standard with each and every couple, I think the merger will create something even better than the sum of its parts,” Dr. Onwubalili said.